A Phase 2 interventional study of soluble fibre complex and medium chain triglycerides and cellulose and soybean oil in People Who Are Overweight or Obesity, sponsored by Canadian Center for Functional Medicine. Completed at 1 site in Canada. Open to participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2015-10-02.
Sponsored by Canadian Center for Functional Medicine · Phase 2, Interventional, and Treatment
The purpose of this study is to investigate whether the addition of capsules containing soluble fibre complex emulsified with medium chain triglycerides and taken before with meals will lead to a significant amount of weight loss, reduced glycemic volatility and diminished cardio metabolic risk factors in overweight and obese individuals when compared to a placebo control.
We believe that those participants taking 3-6 capsules per day of the treatment capsules over a 14 week period will loose a significant amount of weight compared to the placebo group.
6,570 studies on the registry are indexed under Obesity; 1,718 are open to participants now.
This study's enrollment of 138 is above the median of 77 across 5,084 interventional studies indexed under Obesity.
Browse Obesity studies →Canadian Center for Functional Medicine is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-
cellulose and soybean oil
Dietary Supplement: cellulose and soybean oil
soluble fibre complex and medium chain triglycerides
Dietary Supplement: soluble fibre complex and medium chain triglycerides
weight loss
Time frame: baseline, biweekly and final visit
glycemic volatility and cardio metabolic risk factors
Time frame: baseline and final visit
This study is completed, as verified in Sep 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Canadian Center for Functional Medicine